These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27677429)

  • 21. Thymoquinone suppresses platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferation, migration and neointimal formation.
    Zhu N; Xiang Y; Zhao X; Cai C; Chen H; Jiang W; Wang Y; Zeng C
    J Cell Mol Med; 2019 Dec; 23(12):8482-8492. PubMed ID: 31638340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvianolic acid B inhibits SDF-1α-stimulated cell proliferation and migration of vascular smooth muscle cells by suppressing CXCR4 receptor.
    Pan CH; Chen CW; Sheu MJ; Wu CH
    Vascul Pharmacol; 2012; 56(1-2):98-105. PubMed ID: 22166584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects of herbal decoction Ojeoksan on proliferation and migration in vascular smooth muscle cells.
    Han BH; Yoon JJ; Kim HY; Ahn YM; Jin SN; Wen JF; Lee HS; Lee YJ; Kang DG
    J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31443091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective Deletion of Leptin Signaling in Endothelial Cells Enhances Neointima Formation and Phenocopies the Vascular Effects of Diet-Induced Obesity in Mice.
    Hubert A; Bochenek ML; Schütz E; Gogiraju R; Münzel T; Schäfer K
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1683-1697. PubMed ID: 28705795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of 2,3,4',5-tetrahydroxystilbene-2-0-β-D glucoside on neointima formation in a rat artery balloon injury model and its possible mechanisms.
    Xu XL; Ling DY; Zhu QY; Fan WJ; Zhang W
    Eur J Pharmacol; 2013 Jan; 698(1-3):370-8. PubMed ID: 23178522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BET bromodomain-containing epigenetic reader proteins regulate vascular smooth muscle cell proliferation and neointima formation.
    Dutzmann J; Haertlé M; Daniel JM; Kloss F; Musmann RJ; Kalies K; Knöpp K; Pilowski C; Sirisko M; Sieweke JT; Bauersachs J; Sedding DG; Gegel S
    Cardiovasc Res; 2021 Feb; 117(3):850-862. PubMed ID: 32353113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.
    Duran-Prado M; Morell M; Delgado-Maroto V; Castaño JP; Aneiros-Fernandez J; de Lecea L; Culler MD; Hernandez-Cortes P; O'Valle F; Delgado M
    Circ Res; 2013 May; 112(11):1444-55. PubMed ID: 23595952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydroaustrasulfone alcohol inhibits PDGF-induced proliferation and migration of human aortic smooth muscle cells through inhibition of the cell cycle.
    Chen YC; Wen ZH; Lee YH; Chen CL; Hung HC; Chen CH; Chen WF; Tsai MC
    Mar Drugs; 2015 Apr; 13(4):2390-406. PubMed ID: 25898413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear factor of activated T cells c1 mediates p21-activated kinase 1 activation in the modulation of chemokine-induced human aortic smooth muscle cell F-actin stress fiber formation, migration, and proliferation and injury-induced vascular wall remodeling.
    Kundumani-Sridharan V; Singh NK; Kumar S; Gadepalli R; Rao GN
    J Biol Chem; 2013 Jul; 288(30):22150-62. PubMed ID: 23737530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
    Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
    FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alkaloid rich fraction from Nelumbo nucifera targets VSMC proliferation and migration to suppress restenosis in balloon-injured rat carotid artery.
    Jun MY; Karki R; Paudel KR; Sharma BR; Adhikari D; Kim DW
    Atherosclerosis; 2016 May; 248():179-89. PubMed ID: 27018542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury.
    Hur KY; Seo HJ; Kang ES; Kim SH; Song S; Kim EH; Lim S; Choi C; Heo JH; Hwang KC; Ahn CW; Cha BS; Jung M; Lee HC
    Eur J Pharmacol; 2008 May; 586(1-3):226-33. PubMed ID: 18387604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cinaciguat prevents neointima formation after arterial injury by decreasing vascular smooth muscle cell migration and proliferation.
    Hirschberg K; Tarcea V; Páli S; Barnucz E; Gwanmesia PN; Korkmaz S; Radovits T; Loganathan S; Merkely B; Karck M; Szabó G
    Int J Cardiol; 2013 Jul; 167(2):470-7. PubMed ID: 22357420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of activation of signal transducer and activator of transcription-5B signaling in the vessel wall reduces balloon injury-induced neointima formation.
    Kundumani-Sridharan V; Wang D; Karpurapu M; Liu Z; Zhang C; Dronadula N; Rao GN
    Am J Pathol; 2007 Oct; 171(4):1381-94. PubMed ID: 17823285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
    Ashino T; Yamamoto M; Yoshida T; Numazawa S
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human interleukin-10 inhibits proliferation of vascular smooth muscle cells stimulated by advanced glycation end products and neointima hyperplasia after carotid injury in the rat.
    Ouyang P; Peng LS; Yang H; Peng WL; Wu WY; Xu AL
    Sheng Li Xue Bao; 2003 Apr; 55(2):128-34. PubMed ID: 12715099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation.
    Kong BS; Im SJ; Lee YJ; Cho YH; Do YR; Byun JW; Ku CR; Lee EJ
    PLoS One; 2016; 11(3):e0149394. PubMed ID: 27002821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
    Wu B; Mottola G; Chatterjee A; Lance KD; Chen M; Siguenza IO; Desai TA; Conte MS
    J Vasc Surg; 2017 Jan; 65(1):207-217.e3. PubMed ID: 27034112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation.
    Choi SH; Park S; Oh CJ; Leem J; Park KG; Lee IK
    Vascul Pharmacol; 2015 Oct; 73():11-9. PubMed ID: 26187356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation.
    Daniel JM; Dutzmann J; Bielenberg W; Widmer-Teske R; Gündüz D; Hamm CW; Sedding DG
    Basic Res Cardiol; 2012 May; 107(3):261. PubMed ID: 22418922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.